KEYNOTE-199 cohorts 4 and 5: Pembrolizumab (pembro) plus enzalutamide (enza) for enza-resistant metastatic castration-resistant prostate cancer (mCRPC)

Autor:	R. McDermott, J.N. Graff, E.S. Antonarakis, C.J. Hoimes, S.T. Tagawa, C. Hwang, D. Kilari, A.J.T. Tije, A. Omlin, U.N. Vaishampayan, A. Elliott, H. Wu, J. Kim, C. Schloss, J.S. De Bono
Jazyk:	angličtina
Rok vydání:	2020
Předmět:	Diseases of the genitourinary system. Urology RC870-923 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Zdroj:	European Urology Open Science, Vol 19, Iss , Pp e885-e886 (2020)
Druh dokumentu:	article
ISSN:	2666-1683
DOI:	10.1016/S2666-1683(20)33171-2
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/060d8cb1019a44a3ad05a35244f2f600 Zobrazit plný text záznamu View record in DOAJ